awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37568306-9BBB24B5-50C2-4D0F-8C13-2EA6ECA57E8F
Q37568306-9BBB24B5-50C2-4D0F-8C13-2EA6ECA57E8F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37568306-9BBB24B5-50C2-4D0F-8C13-2EA6ECA57E8F
Quantitative Evaluation of Tumor Early Response to a Vascular-Disrupting Agent with Dynamic PET.
P2860
Q37568306-9BBB24B5-50C2-4D0F-8C13-2EA6ECA57E8F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37568306-9BBB24B5-50C2-4D0F-8C13-2EA6ECA57E8F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1c2d11a2c390165608fe45ddde6a00cdd9777e81
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer